Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |